Celltrion Inc
2 products tracked · names used in filings: Celltrion Inc
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Wed 21 Jan 2026🇺🇸 FDA approval
FDA approves biosimilar Avtozma (tocilizumab-anoh)
Celltrion Inc; BLA761498; Biosimilar; injectable · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Avtozma tocilizumab-anoh | Approved | 2026-01-21 |
| 🇺🇸 | Eydenzelt aflibercept-boav | Approved | 2025-10-02 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.